latest news stock values companies glp-1 obesity cardiometabolic A new Science Perspective highlights the growing body of evidence that hints at the potential of GLP-1โbased medications in treating conditions other than diabetes and obesity, including cardiovascular disease and neurodegenerative disorders ๐ New late-stage clinical trial
Pay in 4 interest-free payments of $6.08 Learn more
Shipping Estimate
USA
- USA
- CAN
- USA
- CAN
Ships within 48 hours ยท Estimated delivery Aug 23 - Aug 28

























